Cargando…
Presenilins as Drug Targets for Alzheimer’s Disease—Recent Insights from Cell Biology and Electrophysiology as Novel Opportunities in Drug Development
A major cause underlying familial Alzheimer’s disease (AD) are mutations in presenilin proteins, presenilin 1 (PS1) and presenilin 2 (PS2). Presenilins are components of the γ-secretase complex which, when mutated, can affect amyloid precursor protein (APP) processing to toxic forms of amyloid beta...
Autores principales: | Duncan, R. Scott, Song, Bob, Koulen, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032171/ https://www.ncbi.nlm.nih.gov/pubmed/29857474 http://dx.doi.org/10.3390/ijms19061621 |
Ejemplares similares
-
Discovery of novel benzophenone integrated derivatives as anti-Alzheimer’s agents targeting presenilin-1 and presenilin-2 inhibition: A computational approach
por: Martiz, Reshma Mary, et al.
Publicado: (2022) -
Presenilins in Alzheimer’s disease and frontotemporal dementia
por: Shen, Jie
Publicado: (2012) -
Function and dysfunction of presenilin in Alzheimer’s disease
por: Shen, Jie
Publicado: (2013) -
Structural biology of presenilin 1 complexes
por: Li, Yi, et al.
Publicado: (2014) -
Modeling Presenilin-Dependent Familial Alzheimer's Disease: Emphasis on Presenilin Substrate-Mediated Signaling and Synaptic Function
por: Parent, Angèle T., et al.
Publicado: (2010)